×
Nyxoah SA Net Profit Margin 2021-2024 | NYXH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Nyxoah SA net profit margin from 2021 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Nyxoah SA Net Profit Margin 2021-2024 | NYXH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Nyxoah SA net profit margin from 2021 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$37.7B
Tempus AI (TEM)
$8B
Hims & Hers Health (HIMS)
$7B
Inspire Medical Systems (INSP)
$5.7B
IRhythm Technologies (IRTC)
$3.5B
Privia Health (PRVA)
$2.7B
Enovis (ENOV)
$2.7B
Azenta (AZTA)
$2.4B
Clover Health Investments (CLOV)
$2.2B
Omnicell (OMCL)
$2.1B
Schrodinger (SDGR)
$1.8B
10x Genomics (TXG)
$1.8B
Phreesia (PHR)
$1.7B
Butterfly Network (BFLY)
$748M
Standard BioTools (LAB)
$588M
Talkspace (TALK)
$537M
Fulgent Genetics (FLGT)
$515M
TruBridge (TBRG)
$362M
Health Catalyst (HCAT)
$343M
SOPHiA GENETICS SA (SOPH)
$235M
Pulmonx (LUNG)
$230M
American Well (AMWL)
$169M
EUDA Health Holdings (EUDA)
$96M
P3 Health Partners (PIII)
$69M
CareCloud (CCLD)
$58M
HeartBeam (BEAT)
$58M
111 (YI)
$47M
Outset Medical (OM)
$44M
Zepp Health (ZEPP)
$42M
SHL Telemedicine (SHLT)
$42M